Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 12—December 2006
Research

Influenza, Campylobacter and Mycoplasma Infections, and Hospital Admissions for Guillain-Barré Syndrome, England

Clarence C. Tam*†Comments to Author , Sarah J. O’Brien‡, and Laura C. Rodrigues*
Author affiliations: *London School of Hygiene and Tropical Medicine, London, United Kingdom; †Health Protection Agency, London, United Kingdom; ‡University of Manchester, Manchester, United Kingdom

Main Article

Table 4

Poisson regression of Guillain-Barré syndrome (GBS) admissions against infection reports, England, 1993–2002: regression coefficients*†

Age group/pathogenLag no.10% range in laboratory reportsRR99% CIp value
All ages
Influenza040.71.0321.008–1.0570.001
Influenza A039.81.0291.006–1.0540.001
<35 y
Campylobacter472.01.0841.017–1.1560.001
572.01.0741.007–1.1460.004
Mycoplasma pneumoniaeR35.61.0401.002–1.0790.007
R15.61.0431.004–1.0830.004
05.61.0411.002–1.0820.006
35–64 y
Influenza116.91.0511.003–1.1020.006
216.91.0470.999–1.0970.011
>65 y
Influenza014.81.0741.024–1.1260.000
114.81.0511.001–1.1040.008
Influenza A014.31.0751.027–1.1260.000
114.31.0521.004–1.1030.005

*Relative risks (RRs) and 99% confidence intervals (CIs) for significant lags by age group and pathogen.
†RRs represent the relative increase in GBS admissions for every 10% increase in the range of laboratory reports for a given pathogen at a given lag.

*Relative risks (RRs) and 99% confidence intervals (CIs) for significant lags by age group and pathogen.
†RRs represent the relative increase in GBS admissions for every 10% increase in the range of laboratory reports for a given pathogen at a given lag.

*Relative risks (RRs) and 99% confidence intervals (CIs) for significant lags by age group and pathogen.
†RRs represent the relative increase in GBS admissions for every 10% increase in the range of laboratory reports for a given pathogen at a given lag.

Main Article

Page created: October 04, 2011
Page updated: October 04, 2011
Page reviewed: October 04, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external